Publication:
Improving Access to Medicines in Developing Countries : Application of New Institutional Economics to the Analysis of Manufacturing and Distribution Issues

dc.contributor.author Attridge, C. James
dc.contributor.author Preker, Alexander S.
dc.date.accessioned 2013-05-30T13:58:51Z
dc.date.available 2013-05-30T13:58:51Z
dc.date.issued 2005-03
dc.description.abstract This paper examines alternative frameworks for empirical analysis of supply side activities, namely, the manufacture and distribution of medicine, through the application of New Institutional Economics (NIE) concepts. Attention is focused particularly upon the potential utility of ideas from agency theory, transaction cost analysis and contemporary ideas from strategy theory. The major purpose of this paper is to use these theoretical frameworks to provide insight for policy makers, when faced with specific situations, whether in an international agency, or a private company, or in defining a national strategy. The analysis attempts to show the importance of distinctions between ideas of 'make' or 'buy', between 'national self sufficiency' and 'international purchasing' strategies, the limitations of contractual agreements under market governance and the crucial linkages between strategy formulation, strategy implementation and the necessary capabilities to achieve successful performance in practice. The current international situation on the investment, location and capacity of pharmaceutical manufacturing is reviewed and likely future scenarios suggested. Correspondingly current patterns of trade in medicines and their likely development within the context of the WTO and bilateral trade agreements are discussed. Against this background the promise and the pitfalls for new forms of public-private partnerships, which may offer attractive alternatives to conventional structures are evaluated. The implications of alternative future strategic options for national governments in setting the balance between health and industrial policies are examined and in particular the extent to which a national manufacturing capability should be developed or sustained. Similarly the scope for improving low cost distribution systems for medicines, based upon a mix of public and private sector channels, is assessed. We conclude with suggestions for further development of a transaction-based framework. en
dc.identifier http://documents.worldbank.org/curated/en/2005/03/5734207/improving-access-medicines-developing-countries-application-new-institutional-economics-analysis-manufacturing-distribution-issues
dc.identifier.uri http://hdl.handle.net/10986/13668
dc.language English
dc.language.iso en_US
dc.publisher World Bank, Washington, DC
dc.relation.ispartofseries Health, Nutrition and Population (HNP) discussion paper;
dc.rights CC BY 3.0 IGO
dc.rights.holder World Bank
dc.rights.uri http://creativecommons.org/licenses/by/3.0/igo/
dc.subject BILATERAL TRADE
dc.subject BOUNDED RATIONALITY
dc.subject CAPITAL INVESTMENT
dc.subject COMPETITIVE MARKETS
dc.subject COST ANALYSIS
dc.subject DECISION MAKING
dc.subject DEVELOPED COUNTRIES
dc.subject ECONOMIES OF SCALE
dc.subject ECONOMIES OF SCOPE
dc.subject ECONOMISTS
dc.subject EMPIRICAL ANALYSIS
dc.subject EXTERNALITIES
dc.subject EXTERNALITY
dc.subject FREE TRADE
dc.subject GENERAL PRACTICE
dc.subject GNP
dc.subject HEALTH CARE
dc.subject HEALTH OUTCOMES
dc.subject HEALTH POLICY
dc.subject HEALTH SERVICES
dc.subject HIGH SECURITY
dc.subject HIV/AIDS
dc.subject HOSPITALS
dc.subject HUMAN DEVELOPMENT
dc.subject INCOME
dc.subject INDUSTRIAL ECONOMICS
dc.subject INNOVATION
dc.subject INSTITUTIONAL ECONOMICS
dc.subject INTERNATIONAL TRADE
dc.subject LABOR COSTS
dc.subject LATIN AMERICAN
dc.subject MACROECONOMIC CONTEXT
dc.subject MACROECONOMICS
dc.subject MALARIA
dc.subject MARKET COMPETITION
dc.subject MARKETING
dc.subject MEDICINES
dc.subject MICROECONOMICS
dc.subject NUTRITION
dc.subject OPPORTUNISTIC BEHAVIOR
dc.subject PARTNERSHIP
dc.subject PATENTS/INTELLECTUAL
dc.subject PATIENTS
dc.subject POLICY MAKERS
dc.subject POLITICIANS
dc.subject PRIVATE SECTOR
dc.subject PROCUREMENT
dc.subject PRODUCERS
dc.subject PROGNOSIS
dc.subject PROPERTY RIGHTS
dc.subject PUBLIC SECTOR
dc.subject PURCHASING POWER
dc.subject QUALITY STANDARDS
dc.subject RENT SEEKING
dc.subject RENT SEEKING BEHAVIOR
dc.subject SUPPLIERS
dc.subject TARIFF BARRIERS
dc.subject TRANSACTION COSTS
dc.subject new institutional economics
dc.title Improving Access to Medicines in Developing Countries : Application of New Institutional Economics to the Analysis of Manufacturing and Distribution Issues en
dspace.entity.type Publication
okr.doctype Publications & Research :: Working Paper
okr.doctype Publications & Research
okr.docurl http://documents.worldbank.org/curated/en/2005/03/5734207/improving-access-medicines-developing-countries-application-new-institutional-economics-analysis-manufacturing-distribution-issues
okr.globalpractice Macroeconomics and Fiscal Management
okr.globalpractice Finance and Markets
okr.identifier.externaldocumentum 000090341_20050414104054
okr.identifier.internaldocumentum 5734207
okr.identifier.report 32038
okr.language.supported en
okr.pdfurl http://www-wds.worldbank.org/external/default/WDSContentServer/WDSP/IB/2005/04/14/000090341_20050414104054/Rendered/PDF/320380AttridgeImprovingAccessFinal.pdf en
okr.topic Health Monitoring and Evaluation
okr.topic Economic Theory and Research
okr.topic Environmental Economics and Policies
okr.topic Macroeconomics and Economic Growth :: Markets and Market Access
okr.topic Health Economics and Finance
okr.unit Health, Nutrition & Population
okr.volume 1 of 1
Files
Original bundle
Now showing 1 - 2 of 2
Thumbnail Image
Name:
English PDF
Size:
715.88 KB
Format:
Adobe Portable Document Format
Description:
No Thumbnail Available
Name:
English Text
Size:
128.34 KB
Format:
Plain Text
Description:
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Plain Text
Description: